Johnson and Johnson is a major producer of health products and pharmaceuticals. REcently their former CEO William C. Weldon stepped down and announced the promotion of Alex Gorsky. Gorsky has extensive experience within the sales of pharmaceuticals and medical devices within Johnson and Johnson. "As is typical for rising stars at large corporations, Mr. Gorsky held
many jobs after starting with the company in 1988, including running
Johnson & Johnson’s pharmaceutical businesses in Europe, Africa and
the Middle East.". The company has placed a lot of responsibility and confidence in Mr. Gorsky.
However there has been much discussion about the appropriateness of this promotion. Gorsky was the leading executive on the artificial hips that J&J produces and many have not passed inspection. Although there is much concern with this appointment they feel Gorsky is fit for the position. Their primary responsibilities and challenges facing Gorsky are, "fixing the problems at the plants that make
over-the-counter products, ensuring that there are lucrative
prescription drugs in development and addressing a global dip in
consumer use of medical services".
More information can be found at: http://www.blogger.com/blogger.g?blogID=266412629036522626#editor/target=post;postID=5208647846852848374
Given his track record, the move to Alex Gorsky definitely poses a record for J&J. Hopefully for their sake, Gorsky can address and fix both the plant issues and consumer demand.
ReplyDelete